1,366 New COVID-19 Cases Since Thursday at Noon in Mohave County

Published by The Bee News



Bullhead City | Coronavirus | Kingman | Lake Havasu City





0 Comments(s)



January 10, 2022

Reading Time: ( Word Count: )

1,366 New COVID-19 Cases Since Thursday at Noon

& 20 New Deaths Reported

37,898 Total Positive Cases & 1,065 Total Deaths

*First Omicron Case Now in Mohave County (See Below)*

MOHAVE COUNTY, AZ (January 10, 2022) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 1,366 new confirmed COVID-19 cases reported since Thursday at noon. There are also 20 new deaths reported. ALL, but 1 of those deaths are previously reported cases.

Eight of the deaths are from the Bullhead City service area. Three are 60-69; three are 70-79; one is 80-89; one is 90+.

Five of the deaths are from the Lake Havasu City service area. Three are 60-69; two are 70-79.

Seven of the deaths are from the Kingman service area. Three are 50-59 and four are 70-79. One of those final four 70-79 is also one of the 1,366 new positive cases being reported today.

ALL 1,366 new confirmed positive cases remain under investigation.

Of the 1,366 new confirmed cases, there are 530 confirmed cases in the Bullhead City service area. There are 527 new confirmed cases in the Kingman service area. There are 252 new confirmed cases in the Lake Havasu City service area. There are 15 new confirmed cases in the North County service area. There are 33 new confirmed cases in an Undetermined or Unknown area of the county.

Of the 530 new confirmed cases in the Bullhead City area, twenty nine are 0-10; forty two are 11-19; eighty seven are 20-29; sixty five are 30-39; eighty four are 40-49; ninety two are 50-59; eighty four are 60-69; thirty nine are 70-79; eight are 80-89.

Of the 536 new confirmed cases in the Kingman area, twenty six are 0-10; fifty six are 11-19; eighty two are 20-29; seventy five are 30-39; eighty one are 40-49; eighty three are 50-59; eighty three are 60-69; forty one are 70-79 (and one of those is also one of today’s newly reported deaths); seven are 80-89; two are 90+.

Of the 252 new confirmed cases in the Lake Havasu City area, ten are 0-10; sixteen are 11-19; forty five are 20-29; thirty one are 30-39; thirty two are 40-49; thirty seven are 50-59; forty one are 60-69; thirty are 70-79; seven are 80-89; three are 90+.

Of the 15 new confirmed cases in the North County area, one is 0-10; two are 11-19; four are 20-29; one is 30-39; four are 40-49; two are 60-69; one is 70-79.

Of the 33 new confirmed cases in an Unknown/Undermined area of the county, five are 0-10; one is 11-19; four are 20-29; four are 30-39; three are 40-49; six are 50-59; one is 60-69; seven are 70-79; two are 80-89.

TOTAL POSITIVE CASES SINCE 1^ST CASE REPORTED –—–37,898

TOTAL RECOVERED THUS FAR: 29,737

AVERAGE AGE OF CASES SINCE CASE #1: 45.3

AVERAGE AGE OF DEATHS SINCE FIRST DEATH: 72.2

*Mohave County now has its first case of the Omicron variant. ADHS notified the MCDPH today that genetic sequencing performed by Total Arizona Omicron Genomes (TGEN) has identified the first Omicron case in our County. Of 49 samples submitted, one sample (2%) was identified as Omicron. No other information about this specific Omicron case is available at this time.*

CDC scientists will continue working with partners to gather data and virus samples that can be studied to answer important questions regarding the Omicron variant as it spreads in the U.S. and other parts of the world.

In the United States, CDC uses genomic surveillance to track variants of SARS-CoV-2, the virus that causes COVID-19 to more quickly identify and act upon these findings to best protect the public’s health. CDC established multiple ways to connect and share genomic sequence data being produced by CDC, public health laboratories, and commercial diagnostic laboratories within publicly accessible databases maintained by the National Center for Biotechnology Informationexternal icon (NCBI) and the Global Initiative on Sharing Avian Influenza Dataexternal icon (GISAID).

CDC reports that if a variant is circulating at 0.1% frequency, there is a 99% chance that it will be detected in CDC’s national genomic surveillance. CDC has been using genomic surveillance throughout the course of the pandemic to track variants of SARS-CoV-2, the virus that causes COVID-19, and inform public health practice.

The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus and how easily Omicron spreads compared to Delta remains unknown. CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms.

More data are needed to know if Omicron infections, and especially reinfections and breakthrough infections in people who are fully vaccinated, cause more severe illness or death than infection with other variants.

The CDC says Vaccines remain the best public health measure to protect people from COVID-19, slow transmission, and reduce the likelihood of new variants emerging.

MCDPH has been notified of a scam in which citizens receive a call from a person claiming to be employees of the Mohave County Department of Public Health and offering home visits to administer COVID-19 vaccine. The MCDPH does not and will not directly contact residents to offer home-based COVID-19 vaccination appointments.*

IMPORTANT NOTE: As a good reminder, the MCDPH(Mohave County Department of Public Health) only reports confirmed COVID-19 cases and deaths, unlike the ADHS, which reports “probables” as well. Therefore, the county’s numbers and those from the state are not the same.

Even those fully vaccinated can still get COVID-19. The vaccine reduces the severity of the virus and hospitalizations. It does not mean individuals are totally immune from Covid-19.

__________________________________________________________

Updated Current Vaccination Information

The U.S. Food and Drug Administration (FDA) has authorized, and the Centers for Disease Control and Prevention (CDC) has recommended booster doses of all three COVID-19 vaccines available in the United States.

For the latest updated information on booster doses and eligibility, please visit:

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html

https://www.cdc.gov/media/releases/2021/p1021-covid-booster.html

Treatment Options

Monoclonal Antibody Therapy (FDA Emergency Use Authorization)

While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.

Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus like the virus that causes COVID-19. That’s why mAb treatment may help patients who are at high risk for severe symptoms or hospitalization.

The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19.

General eligibility information is below.

Individuals who have tested positive for COVID-19 and are within ten days of onset
Unvaccinated individuals who have had close contact with a COVID positive person
Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person

Each facility has its own standards for administering the Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.

Kingman Regional Medical Center (KRMC)

Website: https://www.azkrmc.com/seeking-medicalcare-covid-19

Phone Number: 928-681-8699

Western Arizona Regional Medical Center (WARMC)

Website: https://www.warmc.com/newsroom/antibody-therapy-now-offered-forcovid19-patients-16364

Phone number: 928-763- 2273

Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)

Phone number: 928-505-1030

Veklury® (Remdesivir) (FDA approved)

Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body.

Veklury® (Remdesivir) is approved for hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.

Protect yourself and others